Global Drug Repositioning Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Drug Repositioning market size was valued at US$ 25700 million in 2023. With growing demand in downstream market, the Drug Repositioning is forecast to a readjusted size of US$ 35860 million by 2030 with a CAGR of 4.9% during review period.
The research report highlights the growth potential of the global Drug Repositioning market. Drug Repositioning are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Repositioning. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Repositioning market.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Key Features:
The report on Drug Repositioning market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug Repositioning market. It may include historical data, market segmentation by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Repositioning market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Repositioning market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug Repositioning industry. This include advancements in Drug Repositioning technology, Drug Repositioning new entrants, Drug Repositioning new investment, and other innovations that are shaping the future of Drug Repositioning.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Repositioning market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Repositioning product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Repositioning market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Repositioning market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Repositioning market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Repositioning industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Repositioning market.
Market Segmentation:
Drug Repositioning market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Drug Repositioning market size was valued at US$ 25700 million in 2023. With growing demand in downstream market, the Drug Repositioning is forecast to a readjusted size of US$ 35860 million by 2030 with a CAGR of 4.9% during review period.
The research report highlights the growth potential of the global Drug Repositioning market. Drug Repositioning are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Repositioning. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Repositioning market.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Key Features:
The report on Drug Repositioning market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug Repositioning market. It may include historical data, market segmentation by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Repositioning market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Repositioning market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug Repositioning industry. This include advancements in Drug Repositioning technology, Drug Repositioning new entrants, Drug Repositioning new investment, and other innovations that are shaping the future of Drug Repositioning.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Repositioning market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Repositioning product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Repositioning market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Repositioning market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Repositioning market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Repositioning industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Repositioning market.
Market Segmentation:
Drug Repositioning market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Generic Drugs
- Clinical Trial Failed Drugs
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Novartis
- Mylan
- Johnson & Johnson
- Pfizer
- Bausch Health
- GSK
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Repositioning Market Size 2019-2030
2.1.2 Drug Repositioning Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Repositioning Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Drug Repositioning Market Size by Type
2.3.1 Drug Repositioning Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Repositioning Market Size Market Share by Type (2019-2024)
2.4 Drug Repositioning Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Others
2.5 Drug Repositioning Market Size by Application
2.5.1 Drug Repositioning Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Repositioning Market Size Market Share by Application (2019-2024)
3 DRUG REPOSITIONING MARKET SIZE BY PLAYER
3.1 Drug Repositioning Market Size Market Share by Players
3.1.1 Global Drug Repositioning Revenue by Players (2019-2024)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2019-2024)
3.2 Global Drug Repositioning Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG REPOSITIONING BY REGIONS
4.1 Drug Repositioning Market Size by Regions (2019-2024)
4.2 Americas Drug Repositioning Market Size Growth (2019-2024)
4.3 APAC Drug Repositioning Market Size Growth (2019-2024)
4.4 Europe Drug Repositioning Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug Repositioning Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Drug Repositioning Market Size by Country (2019-2024)
5.2 Americas Drug Repositioning Market Size by Type (2019-2024)
5.3 Americas Drug Repositioning Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repositioning Market Size by Region (2019-2024)
6.2 APAC Drug Repositioning Market Size by Type (2019-2024)
6.3 APAC Drug Repositioning Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Repositioning by Country (2019-2024)
7.2 Europe Drug Repositioning Market Size by Type (2019-2024)
7.3 Europe Drug Repositioning Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Repositioning by Region (2019-2024)
8.2 Middle East & Africa Drug Repositioning Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug Repositioning Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG REPOSITIONING MARKET FORECAST
10.1 Global Drug Repositioning Forecast by Regions (2025-2030)
10.1.1 Global Drug Repositioning Forecast by Regions (2025-2030)
10.1.2 Americas Drug Repositioning Forecast
10.1.3 APAC Drug Repositioning Forecast
10.1.4 Europe Drug Repositioning Forecast
10.1.5 Middle East & Africa Drug Repositioning Forecast
10.2 Americas Drug Repositioning Forecast by Country (2025-2030)
10.2.1 United States Drug Repositioning Market Forecast
10.2.2 Canada Drug Repositioning Market Forecast
10.2.3 Mexico Drug Repositioning Market Forecast
10.2.4 Brazil Drug Repositioning Market Forecast
10.3 APAC Drug Repositioning Forecast by Region (2025-2030)
10.3.1 China Drug Repositioning Market Forecast
10.3.2 Japan Drug Repositioning Market Forecast
10.3.3 Korea Drug Repositioning Market Forecast
10.3.4 Southeast Asia Drug Repositioning Market Forecast
10.3.5 India Drug Repositioning Market Forecast
10.3.6 Australia Drug Repositioning Market Forecast
10.4 Europe Drug Repositioning Forecast by Country (2025-2030)
10.4.1 Germany Drug Repositioning Market Forecast
10.4.2 France Drug Repositioning Market Forecast
10.4.3 UK Drug Repositioning Market Forecast
10.4.4 Italy Drug Repositioning Market Forecast
10.4.5 Russia Drug Repositioning Market Forecast
10.5 Middle East & Africa Drug Repositioning Forecast by Region (2025-2030)
10.5.1 Egypt Drug Repositioning Market Forecast
10.5.2 South Africa Drug Repositioning Market Forecast
10.5.3 Israel Drug Repositioning Market Forecast
10.5.4 Turkey Drug Repositioning Market Forecast
10.5.5 GCC Countries Drug Repositioning Market Forecast
10.6 Global Drug Repositioning Forecast by Type (2025-2030)
10.7 Global Drug Repositioning Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Drug Repositioning Product Offered
11.1.3 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drug Repositioning Product Offered
11.2.3 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Drug Repositioning Product Offered
11.3.3 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Drug Repositioning Product Offered
11.4.3 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Drug Repositioning Product Offered
11.5.3 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Information
11.6.2 Bausch Health Drug Repositioning Product Offered
11.6.3 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bausch Health Main Business Overview
11.6.5 Bausch Health Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Drug Repositioning Product Offered
11.7.3 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Information
11.8.2 ChemRar Group Drug Repositioning Product Offered
11.8.3 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ChemRar Group Main Business Overview
11.8.5 ChemRar Group Latest Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Drug Repositioning Product Offered
11.9.3 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Glenmark Main Business Overview
11.9.5 Glenmark Latest Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Information
11.10.2 Fujifilm Drug Repositioning Product Offered
11.10.3 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Main Business Overview
11.10.5 Fujifilm Latest Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Information
11.11.2 Dr. Reddy Drug Repositioning Product Offered
11.11.3 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Dr. Reddy Main Business Overview
11.11.5 Dr. Reddy Latest Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Information
11.12.2 R-Pharma Drug Repositioning Product Offered
11.12.3 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 R-Pharma Main Business Overview
11.12.5 R-Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Repositioning Market Size 2019-2030
2.1.2 Drug Repositioning Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Repositioning Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Drug Repositioning Market Size by Type
2.3.1 Drug Repositioning Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Repositioning Market Size Market Share by Type (2019-2024)
2.4 Drug Repositioning Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Others
2.5 Drug Repositioning Market Size by Application
2.5.1 Drug Repositioning Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Repositioning Market Size Market Share by Application (2019-2024)
3 DRUG REPOSITIONING MARKET SIZE BY PLAYER
3.1 Drug Repositioning Market Size Market Share by Players
3.1.1 Global Drug Repositioning Revenue by Players (2019-2024)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2019-2024)
3.2 Global Drug Repositioning Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG REPOSITIONING BY REGIONS
4.1 Drug Repositioning Market Size by Regions (2019-2024)
4.2 Americas Drug Repositioning Market Size Growth (2019-2024)
4.3 APAC Drug Repositioning Market Size Growth (2019-2024)
4.4 Europe Drug Repositioning Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug Repositioning Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Drug Repositioning Market Size by Country (2019-2024)
5.2 Americas Drug Repositioning Market Size by Type (2019-2024)
5.3 Americas Drug Repositioning Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repositioning Market Size by Region (2019-2024)
6.2 APAC Drug Repositioning Market Size by Type (2019-2024)
6.3 APAC Drug Repositioning Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Repositioning by Country (2019-2024)
7.2 Europe Drug Repositioning Market Size by Type (2019-2024)
7.3 Europe Drug Repositioning Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Repositioning by Region (2019-2024)
8.2 Middle East & Africa Drug Repositioning Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug Repositioning Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG REPOSITIONING MARKET FORECAST
10.1 Global Drug Repositioning Forecast by Regions (2025-2030)
10.1.1 Global Drug Repositioning Forecast by Regions (2025-2030)
10.1.2 Americas Drug Repositioning Forecast
10.1.3 APAC Drug Repositioning Forecast
10.1.4 Europe Drug Repositioning Forecast
10.1.5 Middle East & Africa Drug Repositioning Forecast
10.2 Americas Drug Repositioning Forecast by Country (2025-2030)
10.2.1 United States Drug Repositioning Market Forecast
10.2.2 Canada Drug Repositioning Market Forecast
10.2.3 Mexico Drug Repositioning Market Forecast
10.2.4 Brazil Drug Repositioning Market Forecast
10.3 APAC Drug Repositioning Forecast by Region (2025-2030)
10.3.1 China Drug Repositioning Market Forecast
10.3.2 Japan Drug Repositioning Market Forecast
10.3.3 Korea Drug Repositioning Market Forecast
10.3.4 Southeast Asia Drug Repositioning Market Forecast
10.3.5 India Drug Repositioning Market Forecast
10.3.6 Australia Drug Repositioning Market Forecast
10.4 Europe Drug Repositioning Forecast by Country (2025-2030)
10.4.1 Germany Drug Repositioning Market Forecast
10.4.2 France Drug Repositioning Market Forecast
10.4.3 UK Drug Repositioning Market Forecast
10.4.4 Italy Drug Repositioning Market Forecast
10.4.5 Russia Drug Repositioning Market Forecast
10.5 Middle East & Africa Drug Repositioning Forecast by Region (2025-2030)
10.5.1 Egypt Drug Repositioning Market Forecast
10.5.2 South Africa Drug Repositioning Market Forecast
10.5.3 Israel Drug Repositioning Market Forecast
10.5.4 Turkey Drug Repositioning Market Forecast
10.5.5 GCC Countries Drug Repositioning Market Forecast
10.6 Global Drug Repositioning Forecast by Type (2025-2030)
10.7 Global Drug Repositioning Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Drug Repositioning Product Offered
11.1.3 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drug Repositioning Product Offered
11.2.3 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Drug Repositioning Product Offered
11.3.3 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Drug Repositioning Product Offered
11.4.3 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Drug Repositioning Product Offered
11.5.3 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Information
11.6.2 Bausch Health Drug Repositioning Product Offered
11.6.3 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bausch Health Main Business Overview
11.6.5 Bausch Health Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Drug Repositioning Product Offered
11.7.3 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Information
11.8.2 ChemRar Group Drug Repositioning Product Offered
11.8.3 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ChemRar Group Main Business Overview
11.8.5 ChemRar Group Latest Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Drug Repositioning Product Offered
11.9.3 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Glenmark Main Business Overview
11.9.5 Glenmark Latest Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Information
11.10.2 Fujifilm Drug Repositioning Product Offered
11.10.3 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Main Business Overview
11.10.5 Fujifilm Latest Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Information
11.11.2 Dr. Reddy Drug Repositioning Product Offered
11.11.3 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Dr. Reddy Main Business Overview
11.11.5 Dr. Reddy Latest Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Information
11.12.2 R-Pharma Drug Repositioning Product Offered
11.12.3 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 R-Pharma Main Business Overview
11.12.5 R-Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Repositioning Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Drug Repositioning Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 7. Drug Repositioning Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 10. Global Drug Repositioning Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Drug Repositioning Revenue Market Share by Player (2019-2024)
Table 12. Drug Repositioning Key Players Head office and Products Offered
Table 13. Drug Repositioning Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repositioning Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Drug Repositioning Market Size Market Share by Regions (2019-2024)
Table 18. Global Drug Repositioning Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Drug Repositioning Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Drug Repositioning Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Drug Repositioning Market Size Market Share by Country (2019-2024)
Table 22. Americas Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 24. Americas Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 26. APAC Drug Repositioning Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Drug Repositioning Market Size Market Share by Region (2019-2024)
Table 28. APAC Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 30. APAC Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 32. Europe Drug Repositioning Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Drug Repositioning Market Size Market Share by Country (2019-2024)
Table 34. Europe Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 36. Europe Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Drug Repositioning Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Drug Repositioning
Table 45. Key Market Challenges & Risks of Drug Repositioning
Table 46. Key Industry Trends of Drug Repositioning
Table 47. Global Drug Repositioning Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Drug Repositioning Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Drug Repositioning Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Drug Repositioning Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Teva Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 52. Teva Drug Repositioning Product Offered
Table 53. Teva Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 57. Novartis Drug Repositioning Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Mylan Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 62. Mylan Drug Repositioning Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Mylan Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 67. Johnson & Johnson Drug Repositioning Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Pfizer Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 72. Pfizer Drug Repositioning Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Bausch Health Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 77. Bausch Health Drug Repositioning Product Offered
Table 78. Bausch Health Main Business
Table 79. Bausch Health Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bausch Health Latest Developments
Table 81. GSK Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 82. GSK Drug Repositioning Product Offered
Table 83. GSK Main Business
Table 84. GSK Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GSK Latest Developments
Table 86. ChemRar Group Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 87. ChemRar Group Drug Repositioning Product Offered
Table 88. ChemRar Group Main Business
Table 89. ChemRar Group Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ChemRar Group Latest Developments
Table 91. Glenmark Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 92. Glenmark Drug Repositioning Product Offered
Table 93. Glenmark Main Business
Table 94. Glenmark Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Latest Developments
Table 96. Fujifilm Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 97. Fujifilm Drug Repositioning Product Offered
Table 98. Fujifilm Main Business
Table 99. Fujifilm Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Latest Developments
Table 101. Dr. Reddy Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 102. Dr. Reddy Drug Repositioning Product Offered
Table 103. Dr. Reddy Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Dr. Reddy Main Business
Table 105. Dr. Reddy Latest Developments
Table 106. R-Pharma Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 107. R-Pharma Drug Repositioning Product Offered
Table 108. R-Pharma Main Business
Table 109. R-Pharma Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. R-Pharma Latest Developments
Table 1. Drug Repositioning Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Drug Repositioning Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 7. Drug Repositioning Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 10. Global Drug Repositioning Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Drug Repositioning Revenue Market Share by Player (2019-2024)
Table 12. Drug Repositioning Key Players Head office and Products Offered
Table 13. Drug Repositioning Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repositioning Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Drug Repositioning Market Size Market Share by Regions (2019-2024)
Table 18. Global Drug Repositioning Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Drug Repositioning Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Drug Repositioning Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Drug Repositioning Market Size Market Share by Country (2019-2024)
Table 22. Americas Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 24. Americas Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 26. APAC Drug Repositioning Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Drug Repositioning Market Size Market Share by Region (2019-2024)
Table 28. APAC Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 30. APAC Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 32. Europe Drug Repositioning Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Drug Repositioning Market Size Market Share by Country (2019-2024)
Table 34. Europe Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 36. Europe Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Drug Repositioning Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Drug Repositioning Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Drug Repositioning Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Drug Repositioning
Table 45. Key Market Challenges & Risks of Drug Repositioning
Table 46. Key Industry Trends of Drug Repositioning
Table 47. Global Drug Repositioning Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Drug Repositioning Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Drug Repositioning Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Drug Repositioning Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Teva Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 52. Teva Drug Repositioning Product Offered
Table 53. Teva Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 57. Novartis Drug Repositioning Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Mylan Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 62. Mylan Drug Repositioning Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Mylan Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 67. Johnson & Johnson Drug Repositioning Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Pfizer Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 72. Pfizer Drug Repositioning Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Bausch Health Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 77. Bausch Health Drug Repositioning Product Offered
Table 78. Bausch Health Main Business
Table 79. Bausch Health Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bausch Health Latest Developments
Table 81. GSK Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 82. GSK Drug Repositioning Product Offered
Table 83. GSK Main Business
Table 84. GSK Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GSK Latest Developments
Table 86. ChemRar Group Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 87. ChemRar Group Drug Repositioning Product Offered
Table 88. ChemRar Group Main Business
Table 89. ChemRar Group Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ChemRar Group Latest Developments
Table 91. Glenmark Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 92. Glenmark Drug Repositioning Product Offered
Table 93. Glenmark Main Business
Table 94. Glenmark Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Latest Developments
Table 96. Fujifilm Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 97. Fujifilm Drug Repositioning Product Offered
Table 98. Fujifilm Main Business
Table 99. Fujifilm Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Latest Developments
Table 101. Dr. Reddy Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 102. Dr. Reddy Drug Repositioning Product Offered
Table 103. Dr. Reddy Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Dr. Reddy Main Business
Table 105. Dr. Reddy Latest Developments
Table 106. R-Pharma Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 107. R-Pharma Drug Repositioning Product Offered
Table 108. R-Pharma Main Business
Table 109. R-Pharma Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. R-Pharma Latest Developments
LIST OF FIGURES
Figure 1. Drug Repositioning Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repositioning Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Drug Repositioning Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Drug Repositioning Sales Market Share by Country/Region (2023)
Figure 8. Drug Repositioning Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Drug Repositioning Market Size Market Share by Type in 2023
Figure 10. Drug Repositioning in Cardiovascular Diseases
Figure 11. Global Drug Repositioning Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 12. Drug Repositioning in Mental Illness
Figure 13. Global Drug Repositioning Market: Mental Illness (2019-2024) & ($ Millions)
Figure 14. Drug Repositioning in Cancer
Figure 15. Global Drug Repositioning Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Drug Repositioning in Others
Figure 17. Global Drug Repositioning Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Drug Repositioning Market Size Market Share by Application in 2023
Figure 19. Global Drug Repositioning Revenue Market Share by Player in 2023
Figure 20. Global Drug Repositioning Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 22. APAC Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 23. Europe Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 25. Americas Drug Repositioning Value Market Share by Country in 2023
Figure 26. United States Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Drug Repositioning Market Size Market Share by Region in 2023
Figure 31. APAC Drug Repositioning Market Size Market Share by Type in 2023
Figure 32. APAC Drug Repositioning Market Size Market Share by Application in 2023
Figure 33. China Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Drug Repositioning Market Size Market Share by Country in 2023
Figure 40. Europe Drug Repositioning Market Size Market Share by Type (2019-2024)
Figure 41. Europe Drug Repositioning Market Size Market Share by Application (2019-2024)
Figure 42. Germany Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 56. APAC Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 57. Europe Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 59. United States Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 60. Canada Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 63. China Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 64. Japan Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 65. Korea Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 67. India Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 68. Australia Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 69. Germany Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 70. France Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 71. UK Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 72. Italy Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 73. Russia Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 74. Spain Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 77. Israel Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 80. Global Drug Repositioning Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Drug Repositioning Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Drug Repositioning Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repositioning Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Drug Repositioning Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Drug Repositioning Sales Market Share by Country/Region (2023)
Figure 8. Drug Repositioning Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Drug Repositioning Market Size Market Share by Type in 2023
Figure 10. Drug Repositioning in Cardiovascular Diseases
Figure 11. Global Drug Repositioning Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 12. Drug Repositioning in Mental Illness
Figure 13. Global Drug Repositioning Market: Mental Illness (2019-2024) & ($ Millions)
Figure 14. Drug Repositioning in Cancer
Figure 15. Global Drug Repositioning Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Drug Repositioning in Others
Figure 17. Global Drug Repositioning Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Drug Repositioning Market Size Market Share by Application in 2023
Figure 19. Global Drug Repositioning Revenue Market Share by Player in 2023
Figure 20. Global Drug Repositioning Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 22. APAC Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 23. Europe Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Drug Repositioning Market Size 2019-2024 ($ Millions)
Figure 25. Americas Drug Repositioning Value Market Share by Country in 2023
Figure 26. United States Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Drug Repositioning Market Size Market Share by Region in 2023
Figure 31. APAC Drug Repositioning Market Size Market Share by Type in 2023
Figure 32. APAC Drug Repositioning Market Size Market Share by Application in 2023
Figure 33. China Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Drug Repositioning Market Size Market Share by Country in 2023
Figure 40. Europe Drug Repositioning Market Size Market Share by Type (2019-2024)
Figure 41. Europe Drug Repositioning Market Size Market Share by Application (2019-2024)
Figure 42. Germany Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Drug Repositioning Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 56. APAC Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 57. Europe Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 59. United States Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 60. Canada Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 63. China Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 64. Japan Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 65. Korea Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 67. India Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 68. Australia Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 69. Germany Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 70. France Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 71. UK Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 72. Italy Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 73. Russia Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 74. Spain Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 77. Israel Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Drug Repositioning Market Size 2025-2030 ($ Millions)
Figure 80. Global Drug Repositioning Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Drug Repositioning Market Size Market Share Forecast by Application (2025-2030)
